INNOVA CAPTAB LIMITED·PHARMACEUTICALS 70.24·Pharmaceuticals & Biotechnology Companies

2026-08-21 NSE BSE Web Result 11 Aug

Price

1,088.5

+0.39%
O:1084.2
H:1099.85
L:1073.75
C:1088.5

52W Range

6221120
+75%/-3%

Market Cap

₹6,228.93 Cr

Traded: ₹8.54 Cr (0.14%) 0.0x

Free Float: ₹1,791.44 Cr (0.48% of FF traded)

Volume · 60D trend

78.41 K 0.0x

Delivery: % 0.0x

View Delivery Data

Returns

1W:+0% 1M:+12% 3M:+15% 6M:+47% 12M:+51%

Valuation

P/E40.5
P/B5.7
P/S3.6
EV/EBIT27.9

Business Strength

ROE14.3%
ROCE14.6%
OPM14.9%
NPM10.3%

Growth (3Y CAGR)

EPS+35.9%
Sales+16.0%
Profit+26.0%
3Y Return--

Balance Sheet

Debt/Equity0.3
Debt335 Cr
Pledge0.0%
CWIP/Fixed Asset0.8%

Cash Position

CFO/NP50.0%
FCF-108 Cr
FCF 3Y Avg-260 Cr
Cash/MCap2.0%

Others

Div Yield0.0%
Div Payout0.0%
Cash Conv. Cycle101 days
Tradeable Free Float28.8%

MTF Exposure Trend

60 sessions · funded amount, % of FF, daily delta

Current
₹ 9.60 Cr
0.54% FF
60d high
₹ 11.32 Cr
60d low
₹ 6.36 Cr
60d mean
₹ 7.79 Cr
vs mean
▲ 23.15%

Growth Trends

Metric10Y5Y3Y1YTTMTrend
ROE
--
+19.0%
+17.0%
--
--
Decelerating
Sales
--
+27.0%
+16.0%
--
+26.0%
Stable
Profit
--
+36.0%
+26.0%
--
+4.0%
Decelerating
Return
--
--
--
-11.0%
--
--

Quarterly Results

Jun 2026

11 Aug
Rev
471 Cr
----
OPM16.0%
NPM--
PAT
+42% YoY44 Cr
EPS
--7.7

Mar 2026

7 May
Rev
448 Cr
+42% YoY-0% QoQ
OPM15.0%
NPM8.5%
PAT
+29% YoY38 Cr
EPS
+29% YoY6.7

Dec 2025

23 Jan
Rev
450 Cr
+42% YoY+18% QoQ
OPM15.0%
NPM9.3%
PAT
+23% YoY42 Cr
EPS
+23% YoY7.4

Sep 2025

PDF
Rev
380 Cr
+20% YoY+8% QoQ
OPM14.0%
NPM7.9%
PAT
-15% YoY30 Cr
EPS
-15% YoY5.2

Jun 2025

PDF
Rev
352 Cr
+19% YoY+12% QoQ
OPM15.0%
NPM8.8%
PAT
+5% YoY31 Cr
EPS
+5% YoY5.4

Mar 2025

PDF
Rev
315 Cr
+20% YoY-0% QoQ
OPM15.0%
NPM9.5%
PAT
+3% YoY30 Cr
EPS
+3% YoY5.2

Dec 2024

PDF
Rev
316 Cr
+5% YoY-1% QoQ
OPM15.0%
NPM10.8%
PAT
+36% YoY34 Cr
EPS
+36% YoY6.0

Sep 2024

PDF
Rev
318 Cr
+12% YoY+8% QoQ
OPM16.0%
NPM11.0%
PAT
+53% YoY35 Cr
EPS
+28% YoY6.1

Jun 2024

PDF
Rev
294 Cr
+26% YoY+12% QoQ
OPM14.0%
NPM9.9%
PAT
+68% YoY29 Cr
EPS
+41% YoY5.2

Mar 2024

PDF
Rev
263 Cr
+9% YoY-13% QoQ
OPM14.0%
NPM11.0%
PAT
+66% YoY29 Cr
EPS
+40% YoY5.0

Dec 2023

PDF
Rev
302 Cr
+25% YoY+7% QoQ
OPM15.0%
NPM8.3%
PAT
+28% YoY25 Cr
EPS
+8% YoY4.4

Sep 2023

Rev
283 Cr
+17% YoY+21% QoQ
OPM14.0%
NPM8.1%
PAT
+22% YoY23 Cr
EPS
--4.8

Jun 2023

Rev
233 Cr
---3% QoQ
OPM13.0%
NPM7.7%
PAT
--18 Cr
EPS
--3.7

Mar 2023

Rev
241 Cr
---0% QoQ
OPM11.0%
NPM7.0%
PAT
--17 Cr
EPS
--3.6

Dec 2022

Rev
242 Cr
----
OPM14.0%
NPM8.3%
PAT
--20 Cr
EPS
--4.1

Revenue & Margin Trends

Annual

Quarterly

Balance Sheet Health

Leverage

Debt / Equity0.33
Interest Coverage2.1x
Promoter Pledge0.0%
Borrowings336 Cr

Efficiency

Receivable Days97 days
Inventory Days119 days
Payable Days115 days
Cash Conversion cycle101 days

Cash Position

Operating Cash Flow64 Cr
Investing Cash Flow-152 Cr
Financing Cash Flow92 Cr
Free Cash Flow-108 Cr

Detailed Financials

Jun 2026PDF ↗
Mar 2026PDF ↗
Dec 2025PDF ↗
Sep 2025PDF ↗
Jun 2025PDF ↗
Mar 2025PDF ↗
Dec 2024PDF ↗
Sep 2024PDF ↗
Jun 2024PDF ↗
Mar 2024PDF ↗
Dec 2023PDF ↗
Sep 2023
Jun 2023
Mar 2023
Dec 2022
Sales471448450380352315316318294263302283233241242
Expenses398383381329299267270268252225258242202214208
Operating Profit736569525248475042384540312734
OPM %16.0%15.0%15.0%14.0%15.0%15.0%15.0%16.0%14.0%14.0%15.0%14.0%13.0%11.0%14.0%
Other Income222443422623133
Interest454632000179556
Depreciation121111111110555355333
Profit Before Tax595156394339464739403530252128
Tax %25.0%25.0%24.0%24.0%27.0%25.0%25.0%25.0%25.0%27.0%29.0%24.0%28.0%19.0%31.0%
Net Profit443842303130343529292523181720
Exceptional Items------------------------------
EPS (Rs)7.76.77.45.25.45.26.06.15.25.04.44.83.73.64.1
Sales Growth (YoY)--42.3%42.3%19.5%19.5%19.8%4.6%12.5%26.2%9.0%25.0%16.8%------
Sales Growth (QoQ)---0.4%18.4%8.0%11.8%-0.3%-0.6%8.2%11.8%-12.9%6.7%21.5%-3.3%-0.4%--
OP Growth (YoY)40.4%35.4%46.8%4.0%23.8%26.3%4.4%25.0%35.5%40.7%32.4%--------
OP Growth (QoQ)12.3%-5.8%32.7%0.0%8.3%2.1%-6.0%19.0%10.5%-15.6%12.5%29.0%14.8%-20.6%--
Profit Growth (YoY)42.3%28.8%23.3%-15.2%5.2%3.0%36.1%52.8%67.6%66.5%28.4%22.1%------
EPS Growth (YoY)--28.6%23.2%-15.4%5.2%3.0%36.2%28.3%40.7%39.8%7.6%--------
EPS Growth (QoQ)---9.8%42.3%-4.4%4.8%-13.6%-2.3%18.8%2.6%14.3%-8.0%30.3%1.9%-12.0%--
OP Margin--14.5%15.3%13.7%14.8%15.2%14.9%15.7%14.3%14.4%14.9%14.1%13.3%11.2%14.1%
Net Margin--8.5%9.3%7.9%8.8%9.5%10.8%11.0%9.9%11.0%8.3%8.1%7.7%7.0%8.3%
Material Cost %--66.0%65.0%64.0%63.0%63.0%66.0%65.0%68.0%64.0%67.0%68.0%71.0%75.0%73.0%
Employee Cost %--10.0%10.0%11.0%11.0%11.0%9.0%9.0%8.0%10.0%8.0%9.0%6.0%6.0%6.0%
P/S3.563.583.30------------------------
P/E40.4541.3937.32------------------------
P/B5.715.344.84------------------------

Shareholding Pattern

Shareholders:38.7K (-72.2%)
Current MixDec 2025

Exchange Filings

50
Company Update23 Aug 2026

This is to inform you that the Board of Directors of the Company at its meeting commenced on 21st August 2026 at 23:16 hours (IST) and concluded on 22nd August 2026 at 00:25 hours (IST) ....

Company Update22 Aug 2026

Pursuant to Regulation 30 and other applicable provision Board of Directors approved the AGM Notice. AGM Notice and annual report will be shared in due course.

Company Update22 Aug 2026

In terms of Regulations 30 of the Listing Regulations the Board of Directors of the Company had approved a brownfield expansion of the existing manufacturing facility at 81-BEPIP Phase-1 ....

Result22 Aug 2026

Pursuant to regulation 30(read with Part A of Schedule III) and other applicable provisions of the SEBI LODR 2015 Board of Directors at its meeting commenced on 21st August 2026 has approved ....

Board Meeting22 Aug 2026

Pursuant to regulation 30 (read with Part A of schedule III) and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we ....

Board Meeting18 Aug 2026

Innova Captab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/08/2026 ,inter alia, to consider and approve Pursuant to regulation 29 of ....

Company Update14 Aug 2026

This is in continuation to our letter dated 12th August, 2026, where we have informed regarding the audio link of the earnings call with analysts/investors for the quarter ended 30th June, ....

Insider Trading / SAST13 Aug 2026

Pursuant to the provisions of Securities Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we wish to inform you that in terms of ....

Company Update12 Aug 2026

This is to inform you that the Board of Directors of the Company at its meeting held on Tuesday, 11th August, 2026, has approved the unaudited (standalone and consolidated) financial results ....

Company Update12 Aug 2026

This is further to our intimation letter dated 07th August, 2026, and pursuant to regulation 30 read with part A of schedule lll of the Securities Exchange Board of India (Listing Obligations ....

Board Meeting11 Aug 2026

Pursuant to regulation 30 (read with part A of schedule III) and other applicable provisions of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, ....

Company Update11 Aug 2026

Pursuant to regulation 30 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, ("Listing Regulations"), we are enclosing herewith ....

Company Update11 Aug 2026

Intimation of Investor presentation for the analyst/institutional investor meeting to be held for financial result of quarter ended 30th June 2026.

Result11 Aug 2026

Pursuant to regulation 30 (read with part A of schedule lll) and other applicable provisions of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, ....

Board Meeting06 Aug 2026

Innova Captab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve Pursuant to Regulation 29 of ....

Company Update06 Aug 2026

Pursuant to regulation 29 of the Securities Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulation, 2015, we hereby inform you that the meeting of the Board ....

Company Update03 Jul 2026

Pursuant to Regulation 74(5) of Securities Exchange Board of India (Depositories and Participants) Regulations, 2018 we are enclosing herewith copy of certificate dated 02nd July, 2026 ....

Insider Trading / SAST25 Jun 2026

Pursuant to the Provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time, we wish to inform you that in terms of Company''s Code internal procedures ....

Company Update25 Jun 2026

Pursuant to the regulation 30 read with schedule III, Part A, Para A of SEBI LODR Regulations, 2015, as amended, we are enclosing herewith copies of the newspaper advertisements dated 25th ....

AGM/EGM24 Jun 2026

Pursuant to the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in continuation of our earlier intimation letter dated 04th June, ....

Company Update06 Jun 2026

Pursuant to regulation 30 read with schedule III Part A Para A and Regulation 47 of SEBI (LODR) 2015 as amended time to time and as per SS 2 issued by ICSI we are enclosing herewith copy ....

Company Update05 Jun 2026

Pursuant to Regulation 36(1)(b) of SEBI(LODR)2015 the Company is sending physical to those shareholders whose email address is not registered with Company/Depository Participant/ Depositories ....

AGM/EGM04 Jun 2026

The 22nd Annual General Meeting (AGM) of Members of Innova Captab Limited will be held on Monday 29th June 2026 at 11:00 AM (IST) through Video Conferencing / other Audio Visual Means ("VC"/"OVAM") ....

Others04 Jun 2026

Pursuant to Regulation 34(2)(f) of SEBI (LODR) 2015 please find enclosed Business Responsibility and Sustainability Report (BRSR) for FY 2025-26.

Others04 Jun 2026

The 22nd Annual General Meeting ('AGM') of the Members of Innova Captab Limited will be held on Monday, 29th June, 2026 at 11:00 A.M. (IST) through Video Conferencing/Other Audio Visual ....

Company Update26 May 2026

Intimation under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Change in Composition of Audit Committee of the Board

Company Update26 May 2026

Intimation under regulation 30 of the SEBI (Listing Obligations and Disclosures Requirements) Regulation, 2015 - Change in Composition of Committee of the Board

Others25 May 2026

Pursuant to regulation 30 (read with Part A of Schedule III) and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ('Listing Regulations'), ....

Company Update25 May 2026

Pursuant to regulation 30 (read with Part A Schedule III) and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), ....

Company Update25 May 2026

Pursuant to Regulation 30 of (read with Part A of Schedule III) and other applicable provisions SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ("Listing Regulations"), ....

Company Update20 May 2026

Pursuant to Regulation 30 read with Schedule III (Part A) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to ....

Company Update14 May 2026

This is in continuation to our letter dated 08th May, 2026, wherein we had informed regarding the audio link of the earnings call with analysts/investors for the quarter and financial year ....

Company Update08 May 2026

This is further to our intimation letter dated 30th April, 2026, and pursuant to Regulation 30 read with Part A of Schedule III of the SEBI (LODR) Regulations, 2015, please note that the ....

Company Update08 May 2026

This is to inform you that Board of Directors of the Company at its meeting held on Thursday, 7th May, 2026, has approved the Audited (Standalone and Consolidated) Financial result of the ....

Board Meeting07 May 2026

Pursuant to regulation 30 (read with Part A of Schedule III) and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ('Listing Regulations'), we ....

Result07 May 2026

Pursuant to regulation 30 (read with part A of Schedule III) and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), ....

Company Update07 May 2026

Pursuant to regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Press Release issued by the Company on the Audited Financial ....

Company Update07 May 2026

This is in continuation to our dated 30th April, 2026 wherein we had informed regarding an earnings call Scheduled to be held on Friday 08th May, 2026 at 11.00 am (IST). Please find enclosed ....

Company Update30 Apr 2026

Pursuant to the Regulation 30 read with Schedule III Part A - Para A (15) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the ....

Company Update29 Apr 2026

Pursuant to Regulation 24A of the SEBI (LODR) Regulations, 2015, read with applicable circulars issued by the SEBI, BSE and NSE, from time to time, please find enclosed herewith the Annual ....

Board Meeting29 Apr 2026

Innova Captab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2026 ,inter alia, to consider and approve Pursuant to Regulations 29 of ....

Company Update14 Apr 2026

Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure requirement) Regulations, 2015

Company Update14 Apr 2026

Intimation under regulation 30 of SEBI (LODR), 2015 regarding credit rating.

Company Update08 Apr 2026

Pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, we are enclosing herewith a copy of the certificate dated 07th ....

Insider Trading / SAST02 Apr 2026

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vistra ITCL India Ltd

Insider Trading / SAST01 Apr 2026

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vistra ITCL (India) Ltd

Insider Trading / SAST27 Mar 2026

The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vistra ITCL (India) Ltd

Insider Trading / SAST25 Mar 2026

Pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time, we wish to inform you that in terms of Company''s Code of Internal Procedures ....

Company Update03 Mar 2026

Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like ....

Company Update23 Feb 2026

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015. Pursuant to the Regulation 30 ....

Annual Reports

2

2025

2024

Credit Ratings

6
careRating update
19 Sept 2025Report
careRating update
04 Sept 2024Report
careRating update
27 Sept 2023Report
careRating update
30 May 2023Report
careRating update
07 Feb 2023Report
careRating update
07 Apr 2022Report

Concalls

11

Feb 2026

28 Feb 2026

Feb 2026

28 Feb 2026

Nov 2025

30 Nov 2025

Aug 2025

31 Aug 2025

May 2025

31 May 2025

Feb 2025

28 Feb 2025

Nov 2024

30 Nov 2024

Aug 2024

31 Aug 2024

Jun 2024

30 Jun 2024

May 2024

31 May 2024

Feb 2024

29 Feb 2024

Held by ETFs

1 ETFs hold INNOVACAP · sorted by weight

#ETFWeight %
1

MOHEALTH

MOTILALAMC - MOHEALTH

0.10%

Held by Mutual Funds

11 schemes hold INNOVACAP · sorted by weight

#SchemeWeight %
1

Canara Robeco Manufacturing Fund

Canara Robeco Mutual Fund

1.58%
2

Canara Robeco Value Fund

Canara Robeco Mutual Fund

1.27%
3

Kotak Healthcare Fund

Kotak Mahindra Mutual Fund

1.17%
4

Canara Robeco Small Cap Fund

Canara Robeco Mutual Fund

1.14%
5

Kotak Consumption Fund

Kotak Mahindra Mutual Fund

1.12%
6

WhiteOak Capital Pharma and Healthcare Fund

WhiteOak Capital Mutual Fund

1.05%
7

Kotak Multicap Fund

Kotak Mahindra Mutual Fund

0.62%
8

Bandhan BSE Healthcare Index Fund

Bandhan Mutual Fund

0.10%
9

Bandhan Small Cap Fund

IDFC Mutual Fund

0.08%
10

Motilal Oswal BSE 1000 Index Fund

Motilal Oswal Mutual Fund

0.01%
11

Invesco India Smallcap Fund

Invesco Mutual Fund

0.46%